Study of the solid state of carbamazepine after processing with gas anti-solvent technique.
The purpose of this study was to investigate the influence of supercritical CO2 processing on the physico-chemical properties of carbamazepine, a poorly soluble drug. The gas anti-solvent (GAS) technique was used to precipitate the drug from three different solvents (acetone, ethylacetate and dichloromethane) to study how they would affect the final product. The samples were analysed before and after treatment by scanning electron microscopy analysis and laser granulometry for possible changes in the habitus of the crystals. In addition, the solid state of the samples was studied by means of X-ray powder diffraction, differential scanning calorimetry, diffuse reflectance Fourier-transform infrared spectroscopy and hot stage microscopy. Finally, the in vitro dissolution tests were carried out. The solid state analysis of both samples untreated and treated with CO2, showed that the applied method caused a transition from the starting form III to the form I as well as determined a dramatic change of crystal morphology, resulting in needle-shaped crystals, regardless of the chosen solvent. In order to identify which process was responsible for the above results, carbamazepine was further precipitated from the same three solvents by traditional evaporation method (RV-samples). On the basis of this cross-testing, the solvents were found to be responsible for the reorganisation into a different polymorphic form, and the potential of the GAS process to produce micronic needle shaped particles, with an enhanced dissolution rate compared to the RV-carbamazepine, was ascertained.
Moneghini
M
M
Department of Pharmaceutical Sciences, University of, Trieste, Italy. moneghin@univ.trieste.it
Kikic
I
I
Voinovich
D
D
Perissutti
B
B
Alessi
P
P
Cortesi
A
A
Princivalle
F
F
Solinas
D
D
D002220:Carbamazepine / Q000737:chemistry* / Q000493:pharmacokinetics; D005740:Gases / Q000737:chemistry* / Q000493:pharmacokinetics; D012997:Solvents / Q000737:chemistry* / Q000493:pharmacokinetics; D013678:Technology, Pharmaceutical / Q000379:methods*
D005740:Gases; D012997:Solvents; D002220:Carbamazepine